SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '0Z7'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BCU_H_PRLH280_0 (ALPHA-THROMBIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 6 / 9 | ASP H 189SER H 195VAL H 213TRP H 215GLY H 216GLY H 226 | 0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.41A | 1bcuH-4ylqH:35.3 | 1bcuH-4ylqH:35.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DWC_H_MITH1_1 (ALPHA-THROMBIN(LARGE SUBUNIT)) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 5 / 9 | HIS H 57ASP H 189SER H 195TRP H 215GLY H 226 | 0Z7 H 501 (-2.6A)0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.0A) | 0.49A | 1dwcH-4ylqH:34.6 | 1dwcH-4ylqH:35.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ETR_H_MITH1_1 (EPSILON-THROMBIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 7 / 12 | HIS H 57ASP H 189SER H 195VAL H 213TRP H 215GLY H 216GLY H 226 | 0Z7 H 501 (-2.6A)0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.63A | 1etrH-4ylqH:34.5 | 1etrH-4ylqH:36.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1F5L_A_AMRA301_1 (UROKINASE-TYPEPLASMINOGENACTIVATOR) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 6 / 8 | ASP H 189SER H 190SER H 195VAL H 213GLY H 216GLY H 226 | 0Z7 H 501 (-2.3A)0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.42A | 1f5lA-4ylqH:34.1 | 1f5lA-4ylqH:32.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TNL_A_TPAA900_1 (TRYPSIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 6 / 6 | ASP H 189SER H 190SER H 195VAL H 213GLY H 216GLY H 226 | 0Z7 H 501 (-2.3A)0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.26A | 1tnlA-4ylqH:35.4 | 1tnlA-4ylqH:40.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BR4_D_SAMD301_1 (CEPHALOSPORINHYDROXYLASE CMCI) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 3 / 3 | LYS H 16ASP H 60ASP H 194 | None0Z7 H 501 ( 4.2A)None | 0.95A | 2br4D-4ylqH:undetectable | 2br4D-4ylqH:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IGT_C_SAMC1003_1 (SAM DEPENDENTMETHYLTRANSFERASE) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 4 / 4 | ASP H 189ASP H 186ASP H 146GLY H 223 | 0Z7 H 501 (-2.3A)NoneNonePOL H 509 ( 4.0A) | 1.36A | 2igtC-4ylqH:undetectable | 2igtC-4ylqH:21.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 6 / 6 | ASP H 189SER H 190SER H 195VAL H 213GLY H 216GLY H 226 | 0Z7 H 501 (-2.3A)0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.21A | 2otvA-4ylqH:35.6 | 2otvA-4ylqH:40.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2P16_A_GG2A298_1 (COAGULATION FACTOR X(EC 3.4.21.6)(STUART FACTOR)(STUART-PROWERFACTOR)) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 7 / 12 | ASP H 189SER H 195VAL H 213TRP H 215GLY H 216GLY H 226TYR H 228 | 0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A)None | 0.30A | 2p16A-4ylqH:38.8 | 2p16A-4ylqH:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W26_A_RIVA1001_1 (ACTIVATED FACTOR XAHEAVY CHAIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 8 / 12 | ASP H 189SER H 195VAL H 213TRP H 215GLY H 216GLY H 218GLY H 226TYR H 228 | 0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.5A)0Z7 H 501 (-3.0A)None | 0.32A | 2w26A-4ylqH:38.8 | 2w26A-4ylqH:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GY3_A_PNTA246_0 (CATIONIC TRYPSIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 7 / 11 | HIS H 57ASP H 189SER H 190SER H 195TRP H 215GLY H 216GLY H 226 | 0Z7 H 501 (-2.6A)0Z7 H 501 (-2.3A)0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.40A | 3gy3A-4ylqH:35.2 | 3gy3A-4ylqH:40.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEE_D_30BD500_1 (GENOME POLYPROTEIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 5 / 12 | HIS H 57ASP H 102LYS H 192GLY H 193SER H 195 | 0Z7 H 501 (-2.6A)0Z7 H 501 (-3.3A)0Z7 H 501 (-2.9A)0Z7 H 501 (-3.2A)0Z7 H 501 (-1.4A) | 1.13A | 3keeD-4ylqH:10.4 | 3keeD-4ylqH:22.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RXF_A_4APA9_1 (CATIONIC TRYPSIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 6 / 6 | SER H 190SER H 195VAL H 213TRP H 215GLY H 216GLY H 226 | 0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.37A | 3rxfA-4ylqH:14.5 | 3rxfA-4ylqH:40.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RXH_A_HSMA7_1 (CATIONIC TRYPSIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 5 / 5 | ASP H 189SER H 190SER H 195VAL H 213GLY H 226 | 0Z7 H 501 (-2.3A)0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)0Z7 H 501 (-3.0A) | 0.33A | 3rxhA-4ylqH:35.6 | 3rxhA-4ylqH:40.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1G_A_LNLA701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 5 / 12 | PHE H 59ILE H 212GLY H 193GLY H 44LEU H 33 | NoneNone0Z7 H 501 (-3.2A)NoneNone | 1.06A | 4e1gA-4ylqH:undetectable | 4e1gA-4ylqH:16.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HFP_D_15UD402_1 (PROTHROMBIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 5 / 12 | HIS H 57ASP H 189VAL H 213TRP H 215GLY H 226 | 0Z7 H 501 (-2.6A)0Z7 H 501 (-2.3A)0Z7 H 501 ( 4.7A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.0A) | 0.26A | 4hfpD-4ylqH:34.4 | 4hfpD-4ylqH:35.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 5 / 12 | HIS H 57VAL H 213TRP H 215GLY H 216GLY H 226 | 0Z7 H 501 (-2.6A)0Z7 H 501 ( 4.7A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.33A | 4rn6B-4ylqH:29.5 | 4rn6B-4ylqH:35.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VOP_A_C2FA3001_0 (5-METHYLTETRAHYDROFOLATE HOMOCYSTEINES-METHYLTRANSFERASE) |
4ylq | COAGULATION FACTORVII (Homosapiens) | 5 / 12 | GLY H 226LEU H 121VAL H 53SER H 195ILE H 212 | 0Z7 H 501 (-3.0A)NoneNone0Z7 H 501 (-1.4A)None | 1.06A | 5vopA-4ylqH:undetectable | 5vopA-4ylqH:23.51 |